FDA Clears Profound Medical’s AI Model for Treating Prostate Cancer
Profound Medical (Nasdaq: PROF) has received FDA 510(k) clearance for its second AI model aimed at treating prostate cancer. Profound Medical is a Toronto-based company, which specializes in developing and...
World Health Organization Releases Guidelines for Large Multi-Modal Models (LMMs)
The World Health Organization (WHO) recently released guidelines for the ethics and governance of large multi-modal models (LMMs). In the past year, LMMs like Chat GPT have come...
Cleerly Awarded Best Use of AI in Health Tech
Cleerly, a digital healthcare company offering artificial-intelligence-based software to identify and measure atherosclerosis from Coronary Computed Tomography Angiography (CCTA) imaging tests, was awarded Best in Class for the Best Use...
FDA Clears Sonic DL™ for Cardiac MRI Scans
On June 5, 2023, GE HealthCare announced the FDA 510(k) clearance of Sonic DL™. GE HealthCare reports that Sonic DL™ is a deep learning-based technology intended to capture cardiac MRI...
AI & the FDA
The use of artificial intelligence (AI) in healthcare has been growing rapidly in recent years, and AI-enabled medical devices are playing a larger role in patient care. Such devices may...
NVIDIA Collaborates with Medtronic to Build AI Platform for Endoscopy Devices
NVIDIA collaborates with Medtronic to integrate NVIDIA’s artificial intelligence (AI) technology into Medtronic’s GI Genius Endoscopy Module.
AI and Cancer Diagnostics
Rather than simply reading radiological scans, Ibex Medical Analytics is employing its artificial intelligence (AI)-powered cancer detection solutions to assist pathologists in the lab. Ibex’s Galen Platform is a clinical-grade,...
